1 completed. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
Follow relatlimab: new trials by email Literature Review of relatlimab trials Research Report on relatlimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases Nivolumab, Ipilimumab, Nivolumab + Relatlimab - Metastatic Melanoma, Metastasis to Brain | Early Phase 1 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 1 | 2023-06-06 | 2026-04-06 |
Brain Neoplasms (1) · Melanoma (1)
H. Lee Moffitt Cancer Center and Research Institute (1)
United States (1)
Peter Forsyth, MD (1) · Yolanda Pina, MD (1)